NSC |
Compound |
Enrichment |
Correlation |
NSC 727113 |
Null |
0.0434721470609156 |
-0.064604103 |
NSC 734949 |
4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide |
0.0434721470609156 |
0.13638287 |
NSC 741459 |
(11aS)-8-(3-[(11aS)-2,2-difluoro-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropoxy)-2,2-difluoro-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4 |
0.0434721470609156 |
0.29840527 |
NSC 756375 |
GW811761X |
0.0434721470609156 |
0.33191172 |
NSC 155693 |
6H-Pyrido[4,3-b]carbazolium, 9-methoxy-2,5,11-trimethyl-,iodide |
0.0446159312763235 |
0.026100794 |
NSC 169774 |
Bromocriptine methanesulfonate |
0.0446159312763235 |
0.33270947 |
NSC 254677 |
Phomazarin |
0.0446159312763235 |
-0.1964666 |
NSC 321522 |
Gold(1+), bis(triethylphosphine)-, chloride |
0.0446159312763235 |
0.31294053 |
NSC 335766 |
Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- |
0.0446159312763235 |
0.26477452 |
NSC 352741 |
Null |
0.0446159312763235 |
0.19019036 |